Abstract Details
<< Back to Poster Presentations
Audiologic Outcomes from a Targeted and Enhanced-Targeted cCMV Testing Program - 5-year Northwell Experience
Abstract Summary
cCMV is associated with progressive sensorineural hearing loss (SNHL). A hearing-targeted screening program was instituted at Northwell Health hospitals in 2018, where approximately 1% of babies in the U.S. are born each year. This led to increased CMV awareness. Consequently, infants with symptoms other than a failed hearing test, and those born to women with suspected CMV infection, were also tested and referred to ID and Audiology. Beginning February 2018, 14 babies who failed their newborn hearing screen and were CMV positive on saliva (hearing-targeted cohort) were referred for audiology evaluation. Three were not confirmed cCMV (negative urine), 3 went to outside hospitals with results unavailable to us, and 2 did not show for appointments. Six were seen for diagnostic ABR; 3 were found to have profound sensorineural hearing loss (SNHL) in one ear and one was found to have bilateral asymmetric SNHL. Two children were found to have transient conductive hearing loss (CHL). The average age at initial ABR in this cohort was 7.5 weeks. An expanded-targeted cohort of 24 infants tested for CMV because of IUGR, microcephaly, abnormal head imaging, or prenatal diagnosis of CMV were referred. One child was found to have progressive SNHL, with onset at 3 years of age, 2 are still being investigated for SNHL, and 3 had transient CHL; no others were found to have SNHL. The average age at ABR/OAE in this cohort was 3.3 months, and 9 months at behavioral evaluation. These infants continue to be monitored due to risk for progressive SNHL. Additionally, infants with postnatally acquired CMV are being followed. The presentation's goal is to demonstrate that a systematic, ongoing, enhanced-targeted CMV testing program leads to detection and follow-up of infants at risk for SNHL, and increases awareness of CMV that results in more frequent ID and Audiology referrals of at-risk infants.
Learning Objectives
- Analyze the audiologic outcomes among infants referred for suspected and confirmed cCMV
- Evaluate the effectiveness of an enhanced-targeted CMV testing program in raising awareness of cCMV
- Learn how to adapt a CMV testing program model for your own setting
Presentation
This presentation has not yet been uploaded.
Handouts
Presenters
Kaitlin Iannelli | Primary Presenter, Author
kiannelli@northwell.edu;
Dr. Iannelli is a clinical audiologist who works with all populations of hearing-impaired individuals, from children through adults. Kaitlin received a Bachelor of Science degree in Communication Disorders from the University of Rhode Island and Doctorate of Audiology (Au.D.) from The City University of New York (CUNY) Graduate Center. She completed her internship and residency in Audiology at the Long Island Jewish Hearing and Speech Center, and has been on staff as a clinical audiologist there since 2011. She is currently involved in many aspects of audiological care, including diagnostic assessment of hearing and audiologic habilitation/rehabilitation in pediatric and adult populations, and managing the Newborn Hearing Screening Program. She holds New York State Licensure in Audiology and Hearing Aid Dispensing and Certificate of Clinical Competence in Audiology (CCC-A) from the American Speech-Language Association (ASHA).
ASHA DISCLOSURE
Financial - No relevant financial relationship exists.
Nonfinancial - No relevant nonfinancial relationship exists.
AAA DISCLOSURE
Financial - No relevant financial relationship exists.
Jeffrey Poomkudy | Author, Co-Author
jeffrey.t.poomkudy.20@dartmouth.edu;
Jeffrey Poomkudy was a visiting scholar at the Feinstein Institute, Northwell Health. He graduated Dartmouth College, where he studied philosophy and biology. He is a medical student at Northwestern University Feinberg School of Medicine. He is passionate about studying Infectious Disease and Bioethics, and is an author on presentations and publications related to this CMV project.
ASHA DISCLOSURE
Financial -
Nonfinancial -
AAA DISCLOSURE
Financial - No relevant financial relationship exists.
Sunil Sood | POC-Point of Contact, Co-Presenter, Author
ssood@northwell.edu;
Dr. Sood is a practicing Pediatric Infectious Disease physician and a Professor of Pediatrics. He is an investigator in several NIH-sponsored trials for treatment and follow-up of babies with congenital CMV. His current research focuses on improving recognition and treatment of congenital infections including CMV, Zika and toxoplasmosis. One of his primary goals to increase awareness of these infections among obstetricians and among women of child-bearing age.
ASHA DISCLOSURE
Financial - No relevant financial relationship exists.
Nonfinancial - No relevant nonfinancial relationship exists.
AAA DISCLOSURE
Financial - No relevant financial relationship exists.